TC BioPharm (Holdings) plc Warrants
TCBPW
TCBPW was delisted on the 21st of March, 2025.
6 hedge funds and large institutions have $108K invested in TC BioPharm (Holdings) plc Warrants in 2022 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 3 reducing their positions, and closing their positions.
14% less funds holding
Funds holding: 7 → 6 (-1)
92% less capital invested
Capital invested by funds: $1.36M → $108K (-$1.25M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$253K |
| 2 |
ACM
Altium Capital Management
New York
|
-$127K |
| 3 |
VF
Virtu Financial
New York
|
-$638 |
TCBPW Hedge Fund Activity: Q4 2022 in Review
6 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in TC BioPharm (Holdings) plc Warrants (TCBPW) for Q4 2022, worth a combined $108K — down 92% from $1.36M a quarter earlier.
Fund positioning in TCBPW was balanced in Q4 2022: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 3 trimmed.
The largest seller was Armistice Capital, cutting an estimated $253K.
- 6 institutional investors held TC BioPharm (Holdings) plc Warrants (TCBPW) as of Q4 2022, down from 7 in Q3 2022.
- Funds reported $108K of TC BioPharm (Holdings) plc Warrants stock for Q4 2022, down 92% quarter-over-quarter.
- 0 funds opened new TC BioPharm (Holdings) plc Warrants positions in Q4 2022 and 0 closed out.
- The largest TC BioPharm (Holdings) plc Warrants seller in Q4 2022 was Armistice Capital, an estimated $253K sold.
Based on aggregated 13F filings for Q4 2022.